SCHEMBL30218336

SCHEMBL30218336

N#Cc1ccc(-c2[nH]c3c(F)cc(F)cc3c2/C=C/C(=O)N[C@H]2CCNC2=O)cc1

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ APOL1 O14791 20/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24098954 1.00 APOL1 (0.56) APOL1
SCHEMBL24099512 1.00 APOL1 (0.56) APOL1
SCHEMBL24099167 0.92 APOL1 (0.66) APOL1
SCHEMBL30218335 0.92 APOL1 (0.66) APOL1
SCHEMBL24099508 0.83 APOL1 (0.54) APOL1
SCHEMBL22118330 0.81 APOL1 (0.85) APOL1
SCHEMBL24098926 0.79 APOL1 (0.41) APOL1
SCHEMBL30184356 0.79 APOL1 (0.41) APOL1
SCHEMBL24099510 0.78 APOL1 (0.51) APOL1
SCHEMBL24098932 0.78 APOL1 (0.51) APOL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4165023-A1 INHIBITORS OF APOL1 AND USE OF THE SAME Vertex Pharmaceuticals Incorporated (US) 2023-04-19 — — EP disclosed
CN-115867532-A Inhibitors of APOL1 and uses thereof 弗特克斯药品有限公司 2023-03-28 — — CN disclosed
Send feedback